These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8225532)

  • 41. Renal effects of the new calcium channel blocking drug isradipine.
    Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
    Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natriuretic response to volume expansion in polycystic kidney disease.
    Torres VE; Wilson DM; Offord KP; Burnett JC; Romero JC
    Mayo Clin Proc; 1989 May; 64(5):509-15. PubMed ID: 2725063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opposite effects of enalapril and nitrendipine on natriuretic response to atrial natriuretic factor. Renal function evaluated with clearance studies in humans.
    Gaillard CA; Koomans HA; Rabelink TJ; Boer P; Dorhout Mees EJ
    Hypertension; 1989 Feb; 13(2):173-80. PubMed ID: 2536642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
    Nielsen CB; Pedersen EB
    Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sodium metabolism in essential hypertension. Natriuretic response to acute hypertonic saline load.
    Kubo S; Nishioka A; Takatsu T
    Jpn Heart J; 1978 Nov; 19(6):852-64. PubMed ID: 750669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term effects of isradipine on blood pressure and renal function.
    Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K
    Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension.
    Troughton RW; Lewis LK; Yandle TG; Richards AM; Nicholls MG
    Hypertension; 2000 Oct; 36(4):588-93. PubMed ID: 11040240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans.
    Angeli P; Gatta A; Caregaro L; Menon F; Sacerdoti D; Merkel C; Visoná A; Lusiani L; Pagnan A
    Clin Pharmacol Ther; 1988 Aug; 44(2):211-6. PubMed ID: 2456174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal and endocrine response to saline infusion in essential hypertension.
    Rydstedt LL; Williams GH; Hollenberg NK
    Hypertension; 1986 Mar; 8(3):217-22. PubMed ID: 3005169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
    Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans.
    Dijkhorst-Oei LT; Koomans HA
    Nephrol Dial Transplant; 1998 Mar; 13(3):587-93. PubMed ID: 9550632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natriuretic effect of calcium antagonists.
    Zanchetti A; Leonetti G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S33-7. PubMed ID: 2412009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal haemodynamics and sodium excretory capacity during urapidil treatment in patients with essential hypertension.
    Lavrijssen AT; Kroon AA; Fuss-Lejeune M; Schiffers PM; de Leeuw PW
    J Hypertens; 2000 Jul; 18(7):963-9. PubMed ID: 10930195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proximal sodium reabsorption: An independent determinant of blood pressure response to salt.
    Chiolero A; Maillard M; Nussberger J; Brunner HR; Burnier M
    Hypertension; 2000 Oct; 36(4):631-7. PubMed ID: 11040249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrarenal sodium handling during chronic spironolactone treatment.
    Roos JC; Dorhout Mees EJ; Koomans HA; Boer P
    Nephron; 1984; 38(4):226-32. PubMed ID: 6514071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal perfusion is preserved during cardioselective beta-blockade with metoprolol in hypertension.
    Sugino G; Barg AP; O'Connor DT
    Am J Kidney Dis; 1984 Mar; 3(5):357-61. PubMed ID: 6702821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Propylbutyldopamine. Mechanism of blood pressure lowering in hypertensive patients.
    Taylor AA; Fennell WH; Ruud CO; Pool JL; Nelson EB; Ginos JZ; Mitchell JR
    Hypertension; 1984; 6(2 Pt 2):I40-5. PubMed ID: 6373598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension.
    Koch G; Fransson L; Karlegärd L; Kothari P
    Eur J Clin Pharmacol; 1989; 36(4):343-5. PubMed ID: 2567670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.